Literature DB >> 17910961

Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay.

Chih-Chia Su1, Hiroshi Nikaido, Edward W Yu.   

Abstract

The AcrB of Escherichia coli pumps out a wide range of compounds, including most of the currently available antibiotics, and contributes significantly to the serious problem of multidrug resistance of pathogenic bacteria. Quantitative analysis of drug efflux by this pump requires the measurement of the affinity of ligands. Yet there has been no success in determining these values. We introduce here an approach of steady-state fluorescence polarization to study the interactions between four different ligands and the purified AcrB transporter in a detergent environment. Our assays indicate that the transporter binds these drugs with K(D) values ranging from 5.5 to 74.1microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910961      PMCID: PMC2254335          DOI: 10.1016/j.febslet.2007.09.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Characterization of the multiple transferable resistance repressor, MtrR, from Neisseria gonorrhoeae.

Authors:  Katherine M Hoffmann; Daniel Williams; William M Shafer; Richard G Brennan
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

Review 2.  Multidrug efflux pumps of gram-negative bacteria.

Authors:  H Nikaido
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

3.  A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

Authors:  Edward W Yu; Julio R Aires; Gerry McDermott; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

4.  Investigation of ligand binding to the multidrug resistance protein EmrE by isothermal titration calorimetry.

Authors:  Curtis W Sikora; Raymond J Turner
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

5.  Application of fluorescence energy transfer and polarization to monitor Escherichia coli cAMP receptor protein and lac promoter interaction.

Authors:  T Heyduk; J C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli.

Authors:  H I Zgurskaya; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein.

Authors:  Maria A Schumacher; Marshall C Miller; Richard G Brennan
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

8.  Molecular cloning and characterization of acrA and acrE genes of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

9.  Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.

Authors:  X Z Li; H Nikaido; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

View more
  27 in total

1.  Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli.

Authors:  Keiji Nagano; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 4.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

Review 5.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

Authors:  Hiroshi Nikaido; Jean-Marie Pagès
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

6.  A putative TetR regulator is involved in nitric oxide stress resistance in Porphyromonas gingivalis.

Authors:  M-C Boutrin; Y Yu; C Wang; W Aruni; Y Dou; L Shi; H M Fletcher
Journal:  Mol Oral Microbiol       Date:  2015-10-14       Impact factor: 3.563

7.  Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.

Authors:  Feng Long; Corinne Rouquette-Loughlin; William M Shafer; Edward W Yu
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

Review 8.  Structures of AcrR and CmeR: insight into the mechanisms of transcriptional repression and multi-drug recognition in the TetR family of regulators.

Authors:  Mathew D Routh; Chih-Chia Su; Qijing Zhang; Edward W Yu
Journal:  Biochim Biophys Acta       Date:  2008-12-14

9.  New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors.

Authors:  Laurent Mamelli; Sylvain Petit; Jacqueline Chevalier; Carmela Giglione; Aurélie Lieutaud; Thierry Meinnel; Isabelle Artaud; Jean-Marie Pagès
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

10.  pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon.

Authors:  Ana Martins; Gabriella Spengler; Liliana Rodrigues; Miguel Viveiros; Jorge Ramos; Marta Martins; Isabel Couto; Séamus Fanning; Jean-Marie Pagès; Jean Michel Bolla; Joseph Molnar; Leonard Amaral
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.